Tenax Therapeutics Inc. (TENX)
NASDAQ: TENX
· Real-Time Price · USD
5.90
-0.05 (-0.84%)
At close: Aug 15, 2025, 3:59 PM
6.09
3.22%
After-hours: Aug 15, 2025, 05:30 PM EDT
Tenax Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2K | 2K | 2K | 5.79K | 5.79K | 5.79K | 5.79K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1K | 2K | 2K | 5.67K | 6.67K | 6.67K | 7.57K | 32.1K | 59.61K | 86.62K | 113.33K | 110.96K | 108.71K | 106.37K | 108.98K | 82.15K | 55.88K | 30.22K |
Gross Profit | 1K | n/a | n/a | 120.00 | -880 | -880 | -1.77K | -32.1K | -59.61K | -86.62K | -113.33K | -110.96K | -108.71K | -106.37K | -108.98K | -82.15K | -55.88K | -30.22K |
Operating Income | -50.2M | -42.08M | -34.65M | -16.09M | -18.59M | -16.15M | -13.79M | -20.21M | -19.41M | -21.03M | -16.78M | -437.55K | -7.16M | -6.26M | -32.73M | -32.35M | -30.77M | -30.95M |
Interest Income | 3.58M | 2.73M | 1.8M | 769.61K | 255.62K | 290.6K | 290.6K | 290.6K | 139.86K | 63.00 | 63.00 | 63.00 | 63.00 | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -31.48M | -24.21M | -17.6M | -14.56M | -12.57M | -10.1M | -7.71M | -7.03M | -7.98M | -9.73M | -11.05M | -11.71M | -12.59M | -11.45M | -32.47M | -32.09M | -30.52M | -30.94M |
Net Income | -31.48M | -24.21M | -17.6M | -14.56M | -12.57M | -10.1M | -7.71M | -7.03M | -7.98M | -9.73M | -11.05M | -11.71M | -12.59M | -11.45M | -32.47M | -32.09M | -30.52M | -30.94M |
Selling & General & Admin | 15.53M | 11.21M | 6.79M | 5.73M | 5.27M | 4.96M | 5.01M | 4.78M | 5.11M | 5.41M | 5.68M | 6.55M | 7.81M | 7.75M | 7.58M | 7.23M | 5.76M | 5.36M |
Research & Development | 19.51M | 15.72M | 12.71M | 9.81M | 7.77M | 5.64M | 3.23M | 2.66M | 3.14M | 4.47M | 5.38M | 5.16M | 4.78M | 3.95M | 25.15M | 25.12M | 25.01M | 25.59M |
Other Expenses | 24.4M | 24.4M | 24.4M | 9.79M | 5.55M | 5.55M | 5.55M | -4.23M | -5.83M | -5.83M | -11.27M | -11.27M | -5.44M | -5.44M | n/a | n/a | n/a | n/a |
Operating Expenses | 59.44M | 51.32M | 43.89M | 25.33M | 18.59M | 16.15M | 13.79M | 3.21M | 2.41M | 4.04M | -219.61K | 437.55K | 7.16M | 6.26M | 32.73M | 32.35M | 30.77M | 30.95M |
Interest Expense | 5.85K | 15.04K | 23K | 25.62K | 24.64K | 24.58K | 23.97K | 25.88K | 20.92K | 13.28K | 8.51K | 4.44K | 4.07K | 2.92K | 949.00 | 1.56K | 2.17K | 2.24K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 50.2M | 42.08M | 34.65M | 6.3M | 8.8M | 6.37M | 4M | 3.21M | 2.41M | 4.04M | -219.61K | 437.55K | 7.16M | 6.26M | 32.73M | 32.35M | 30.77M | 30.95M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.07K | -4.07K | -4.07K | -4.07K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 39.57M | 36.58M | 15.27M | 21.16M | 1.96M | 1.22M | 248.45K | 298.28K | 276.45K | 116.26K | 1.47M | 16.46K | 15.75K | 15.75K | 20.58M | 15.75K | 10.76K | 14.52M |
Shares Outstanding (Diluted) | 39.57M | 36.58M | 15.27M | 21.16M | 1.96M | 1.22M | 248.45K | 298.28K | 276.45K | 116.26K | 1.47M | 16.46K | 15.75K | 15.75K | 20.58M | 15.75K | 10.76K | 14.52M |
EPS (Basic) | -0.92 | -2.48 | -5.32 | -15.95 | -22.37 | -24.54 | -33.52 | -124.5 | -295.49 | -473.09 | -633.79 | -746.04 | -809.62 | -787.58 | -3.24K | -3.31K | -3.35K | -3.56K |
EPS (Diluted) | -0.92 | -2.48 | -5.32 | -15.95 | -22.37 | -24.54 | -33.52 | -122.15 | -293.14 | -470.74 | -631.44 | -735.38 | -798.96 | -776.92 | -3.23K | -3.31K | -3.35K | -3.56K |
EBITDA | -31.48M | -24.19M | -17.58M | -14.53M | -12.54M | -10.07M | -7.68M | -6.98M | -7.9M | -9.64M | -10.93M | -11.59M | -12.48M | -11.34M | -32.36M | -31.98M | -30.4M | -30.83M |
EBIT | -31.48M | -24.2M | -17.58M | -14.53M | -12.55M | -10.08M | -7.69M | -7.01M | -7.96M | -9.72M | -11.04M | -11.71M | -12.59M | -11.44M | -32.47M | -32.09M | -30.51M | -30.94M |
Depreciation & Amortization | -1.89K | -892 | 1K | 5.71K | 8.57K | 8.57K | 7.57K | 32.07K | 59.61K | 86.62K | 113.33K | 110.96K | 108.71K | 106.37K | 108.98K | 111.64K | 114.26K | 116.98K |